Engage: A Survivorship Program to Improve Childhood Cancer Survivors' Self-Efficacy and Quality of Life.

IF 4.6 3区 医学 Q1 ONCOLOGY JCO oncology practice Pub Date : 2025-09-01 Epub Date: 2025-02-20 DOI:10.1200/OP-24-00815
Christina Signorelli, Jordana McLoone, Claire Wakefield, Mark Donoghoe, Joseph Elliot Alchin, Karen Johnston, Rachael Baldwin, Elysia Thornton-Benko, Kate Webber, Tali Foreman, Kristen Neville, Richard Cohn
{"title":"Engage: A Survivorship Program to Improve Childhood Cancer Survivors' Self-Efficacy and Quality of Life.","authors":"Christina Signorelli, Jordana McLoone, Claire Wakefield, Mark Donoghoe, Joseph Elliot Alchin, Karen Johnston, Rachael Baldwin, Elysia Thornton-Benko, Kate Webber, Tali Foreman, Kristen Neville, Richard Cohn","doi":"10.1200/OP-24-00815","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>We evaluated a survivorship program Engage, aimed at improving childhood cancer survivors' health-related self-efficacy and their health-related quality of life (HRQoL).</p><p><strong>Materials and methods: </strong>Engage provides (1) a telehealth nurse-led health assessment, (2) a remote multidisciplinary case review, (3) personalized recommendations and care plan for survivors and their primary care physician (PCP), and (4) a telehealth nurse-led consultation to promote survivors' understanding of the recommendations. We recruited survivors >5 years postdiagnosis of any age who had not received cancer-related care in the past 24 months. We assessed survivors' outcomes pre-intervention and at 1-, 6-, 12-, and 24-month follow-ups.</p><p><strong>Results: </strong>Seventy-eight survivors participated: 62% male, median age = 30 years, and 14% lived regionally/rurally. Participating survivors' self-efficacy scores improved from baseline to 1 month and were maintained at 6-, 12-, and 24-month follow-ups (<i>P</i> < .001). Survivors' HRQoL remained similar from baseline to postintervention, as did the proportion of survivors reporting a regular PCP or engaging in health/risky behaviors (eg, exercise). Survivors' distress, anxiety, and anger significantly decreased pre- to 6 months postintervention. Survivors' satisfaction with care increased by 28% (<i>P</i> < .001) and was maintained across follow-up (<i>P</i> = .002). Information needs reduced from baseline to 1 month postintervention (<i>P</i> = .023) although they were similar at further follow-up.</p><p><strong>Conclusion: </strong>Survivors' self-efficacy, satisfaction with care, and some psychosocial outcomes improved after participating in Engage. Further effort is needed to improve survivors' primary care engagement and health behaviors.</p>","PeriodicalId":14612,"journal":{"name":"JCO oncology practice","volume":" ","pages":"1274-1286"},"PeriodicalIF":4.6000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO oncology practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/OP-24-00815","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/20 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: We evaluated a survivorship program Engage, aimed at improving childhood cancer survivors' health-related self-efficacy and their health-related quality of life (HRQoL).

Materials and methods: Engage provides (1) a telehealth nurse-led health assessment, (2) a remote multidisciplinary case review, (3) personalized recommendations and care plan for survivors and their primary care physician (PCP), and (4) a telehealth nurse-led consultation to promote survivors' understanding of the recommendations. We recruited survivors >5 years postdiagnosis of any age who had not received cancer-related care in the past 24 months. We assessed survivors' outcomes pre-intervention and at 1-, 6-, 12-, and 24-month follow-ups.

Results: Seventy-eight survivors participated: 62% male, median age = 30 years, and 14% lived regionally/rurally. Participating survivors' self-efficacy scores improved from baseline to 1 month and were maintained at 6-, 12-, and 24-month follow-ups (P < .001). Survivors' HRQoL remained similar from baseline to postintervention, as did the proportion of survivors reporting a regular PCP or engaging in health/risky behaviors (eg, exercise). Survivors' distress, anxiety, and anger significantly decreased pre- to 6 months postintervention. Survivors' satisfaction with care increased by 28% (P < .001) and was maintained across follow-up (P = .002). Information needs reduced from baseline to 1 month postintervention (P = .023) although they were similar at further follow-up.

Conclusion: Survivors' self-efficacy, satisfaction with care, and some psychosocial outcomes improved after participating in Engage. Further effort is needed to improve survivors' primary care engagement and health behaviors.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
参与:提高儿童癌症幸存者自我效能和生活质量的幸存者计划。
目的:我们评估了一个幸存者项目Engage,旨在提高儿童癌症幸存者的健康相关自我效能感和健康相关生活质量(HRQoL)。材料和方法:Engage提供(1)远程医疗护士主导的健康评估,(2)远程多学科病例回顾,(3)针对幸存者及其初级保健医生(PCP)的个性化建议和护理计划,以及(4)远程医疗护士主导的咨询,以促进幸存者对建议的理解。我们招募了在过去24个月内没有接受过癌症相关治疗的任何年龄的患者,他们在诊断后50岁至50岁之间。我们评估了干预前和1个月、6个月、12个月和24个月随访时的幸存者结果。结果:78名幸存者参与:62%男性,中位年龄= 30岁,14%生活在地区/农村。参与研究的幸存者自我效能评分从基线到1个月有所改善,并在随访6、12和24个月时保持不变(P < 0.001)。幸存者的HRQoL从基线到干预后保持相似,报告定期服用PCP或从事健康/危险行为(如锻炼)的幸存者比例也是如此。幸存者的痛苦、焦虑和愤怒在干预前至干预后6个月显著减少。幸存者对护理的满意度提高了28% (P < 0.001),并在随访期间保持不变(P = 0.002)。从基线到干预后1个月,信息需求减少(P = 0.023),尽管在进一步随访时相似。结论:参与Engage后,幸存者的自我效能感、护理满意度和部分社会心理结局均有改善。需要进一步努力改善幸存者的初级保健参与和健康行为。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.40
自引率
7.50%
发文量
518
期刊最新文献
Video Education With Clinical Genetic Testing Coordinators for the Rapid Evaluation of Patients With Cancers: Real-World Evidence. Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer. Real-World Analysis of Adverse Events in Patients With Triple-Negative Breast Cancer Receiving Therapy per KEYNOTE-522. Characterizing Relationships Between Daily Pain, Opioid Use, and Mood in Patients With Advanced Cancer Using Ecological Momentary Assessments. 340B Drug Pricing Program: An Updated ASCO Policy Statement.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1